Home
About
Overview
Sharing Data
ORCID
Help
History (43)
Extensive cAMP-dependent and cAMP-independent phosphorylation of microtubule-associated protein 2.
Malignant transformation of human cells by constitutive expression of platelet-derived growth factor-BB.
A randomized comparison of a 3-week and 6-week vascular surgery simulation course on junior surgical residents' performance of an end-to-side anastomosis.
Cancer stem cells: cell culture, markers, and targets for new therapies.
The promise of gene therapy for the treatment of alpha-1 antitrypsin deficiency.
See All 43 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The promise of gene therapy for the treatment of alpha-1 antitrypsin deficiency.
Cruz PE, Mueller C, Flotte TR. The promise of gene therapy for the treatment of alpha-1 antitrypsin deficiency. Pharmacogenomics. 2007 Sep; 8(9):1191-8.
View in:
PubMed
subject areas
alpha 1-Antitrypsin Deficiency
Animals
Dependovirus
Disease Models, Animal
Genetic Therapy
Genetic Vectors
Humans
Treatment Outcome
authors with profiles
Terence R Flotte MD